Drug Discovery in Cancer Epigenetics

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Science & Nature, Science, Biological Sciences, Genetics
Cover of the book Drug Discovery in Cancer Epigenetics by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128024928
Publisher: Elsevier Science Publication: November 19, 2015
Imprint: Academic Press Language: English
Author:
ISBN: 9780128024928
Publisher: Elsevier Science
Publication: November 19, 2015
Imprint: Academic Press
Language: English

Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.

  • Highlights the potential of epigenetic alterations in cancer for drug development
  • Covers the tools and methods for epigenetic drug discovery, preclinical and clinical testing, and clinical implications of epigenetic therapy
  • Provides important information regarding putative epigenetic targets, epigenetic technologies, networks and consortia for epigenetic drug discovery and routes for translation
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.

More books from Elsevier Science

Cover of the book Biosensors for Sustainable Food - New Opportunities and Technical Challenges by
Cover of the book Advances in Carbohydrate Chemistry and Biochemistry by
Cover of the book Membrane Protein Crystallization by
Cover of the book Magneto-Resistive and Spin Valve Heads by
Cover of the book Advances in Microbial Physiology by
Cover of the book Plasma Etching by
Cover of the book Microfluidic Cell Culture Systems by
Cover of the book Basic Molecular Protocols in Neuroscience: Tips, Tricks, and Pitfalls by
Cover of the book Windows Forensic Analysis Toolkit by
Cover of the book Treatise on Geochemistry by
Cover of the book Introduction to Groundwater Modeling by
Cover of the book Cumulative Subject and Author Index Including Tables of Contents, Volumes 1-50 by
Cover of the book New and Future Developments in Microbial Biotechnology and Bioengineering by
Cover of the book Characterisation and Design of Tissue Scaffolds by
Cover of the book Orbital Mechanics for Engineering Students by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy